loading

Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten

pulisher
Nov 01, 2024

Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious - Benzinga

Nov 01, 2024
pulisher
Nov 01, 2024

BMS Delivers Q3 Beat, Raises 2024 Guidance Amid Strong Demand for Legacy and Newer Drugs - BioSpace

Nov 01, 2024
pulisher
Nov 01, 2024

Bristol-Myers Squibb Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Bristol-Myers Squibb Co (BMY) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY) - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

A promising schizophrenia drug showed mixed results. What does that mean for patients?WGN Radio - WGN Radio - Chicago

Oct 31, 2024
pulisher
Oct 31, 2024

December 13th Options Now Available For Bristol Myers Squibb (BMY) - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript - The Motley Fool

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers earnings beat expectations, driven by sales of older drugs - Reuters

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers earnings beat expectations, driven by sales of older drugs By Reuters - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024 - BioSpace

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb stock rises, Merck moves lower. Here's why. - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit - Benzinga

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Q3 earnings beat expectations, helped by sales of older drugs - PharmaLive

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers’s stock pops as earnings top estimates and company raises guidance - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Compared to Estimates, Bristol Myers (BMY) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers hikes annual earnings guidance as Q3 exceeds expectations; shares up - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb Co (BMY) Q3 2024 Earnings: Revenue Surpasses Estimates at $11.9 Billion, GAAP EPS at $0.60 - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb's Earnings Surpass Expectations With Strong Drug Sales - Finimize

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers raises outlook ahead of consensus after Q3 beat - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers: Q3 Earnings Snapshot - The Washington Post

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Earnings Top Q3 Estimates; Pharma Giant Raises Guidance - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb Co. Q3 Profit Decreases, But Beats Estimates - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb earnings beat by $0.30, revenue topped estimates - Investing.com South Africa

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Raises Guidance on Demand for Eliquis, New Drugs - BNN Bloomberg

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs - CNBC

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb Q3 24 Earnings Conference Call At 8:00 AM ET - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Areas of interest - Bristol Myers Squibb

Oct 31, 2024
pulisher
Oct 30, 2024

Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Drugmakers urge appeals court to revive challenge to US drug price negotiation program - Reuters

Oct 30, 2024
pulisher
Oct 30, 2024

Bristol Myers Squibb Q3 2024 Earnings Preview: Profit decline anticipated - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Is Eli Lilly Stock a Buy? - The Motley Fool

Oct 30, 2024
pulisher
Oct 30, 2024

Jim Cramer Says Bristol-Myers Squibb Company (BMY) Is ‘Too Low’ - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day - MarketWatch

Oct 29, 2024
pulisher
Oct 28, 2024

Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings? - MSN

Oct 28, 2024
pulisher
Oct 28, 2024

Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

UTSA announces partnership with Bristol Myers Squibb to advance pharmaceutical discoveries and development - The University of Texas at San Antonio

Oct 28, 2024
pulisher
Oct 28, 2024

Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren (NYSE:BMY) - Seeking Alpha

Oct 28, 2024
pulisher
Oct 28, 2024

Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024 - StockTitan

Oct 28, 2024
pulisher
Oct 28, 2024

Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested three years ago - Simply Wall St

Oct 28, 2024
pulisher
Oct 28, 2024

Psoriasis around the world - Bristol Myers Squibb

Oct 28, 2024
pulisher
Oct 26, 2024

Allspring Global Investments Holdings LLC Has $11.12 Million Stake in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

Second Circuit Weighs Whether Bristol-Myers Delayed Cancer Drug - Bloomberg Law

Oct 25, 2024
pulisher
Oct 25, 2024

Citigroup downgrades Bristol-Myers Squibb to 'neutral' - XM

Oct 25, 2024
pulisher
Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024
pulisher
Oct 25, 2024

People and business resource groups - Bristol Myers Squibb

Oct 25, 2024
pulisher
Oct 24, 2024

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Oct 24, 2024
pulisher
Oct 24, 2024

December 6th Options Now Available For Bristol Myers Squibb (BMY) - Nasdaq

Oct 24, 2024
pulisher
Oct 24, 2024

Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Oct 24, 2024
pulisher
Oct 24, 2024

Bristol-Myers Squibb's SWOT analysis: stock faces challenges amid new approvals - Investing.com

Oct 24, 2024
pulisher
Oct 23, 2024

Spain CAR-T Cell Therapy Market Forecast to 2029, Featuring - GlobeNewswire

Oct 23, 2024
pulisher
Oct 23, 2024

Spain CAR-T Cell Therapy Market Forecast to 2029, Featuring Strategic Profiles of Gilead Sciences, Novartis Int'l, Bristol Myers Squibb, AbbVie, AMGEN, Pfizer, Merck & Co, Johnson & Johnson - Yahoo Finance

Oct 23, 2024
$89.51
price up icon 0.78%
drug_manufacturers_general SNY
$53.27
price up icon 0.74%
drug_manufacturers_general PFE
$28.09
price down icon 0.74%
$319.22
price down icon 0.29%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
Kapitalisierung:     |  Volumen (24h):